Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/display. No study content appears to be changed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, signaling a new minor update to the record. This maintenance update does not alter study details or eligibility information.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a new build of the study record.SummaryDifference0.1%

- Check53 days agoChange DetectedThe study page now shows recruitment has ended, and new navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention / Treatment heading was changed to Intervention/Treatment.SummaryDifference0.6%

- Check60 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, representing a new site build. No study details or page content were changed.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing the previous Revision: v3.5.3. This reflects a small update to the page rendering without changes to the study data or content.SummaryDifference0.1%

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.